MedTrace Logo

Enhancing Physical Activity and Healthy Aging Among Recent Retirees

NCT03320746 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 231

Last updated 2020-06-30

No results posted yet for this study

Summary

The purpose of REACT project is to provide cost-effective way to promote physical activity and reduce sedentary time among older adults. This is done by examining the efficacy of activity tracker based intervention on wake-time physical activity, sedentary time, sleep and other health outcomes among recent retirees. REACT study will be the first randomized physical activity trial targeted to time window right after retirement.

Conditions

  • Exercise
  • Aging
  • Retirement

Interventions

DEVICE

Polar Loop 2 activity tracker

The participants were instructed to aim to reach the daily activity goal, initially set at stage 1 as per the goals set by the trackers' manufacturer. The daily activity goal was based on user's typical daily activities, gender and age. The stage 1 daily activity goal corresponded to \~1h/day of jogging or \~2h/day of walking or \~7h/day household activities or a combination of these activities. The tracker gave an inactivity alert as a vibration and text "it's time to move" on the screen of the tracker if the user has been still for 55 minutes.

Sponsors & Collaborators

  • Academy of Finland

    collaborator OTHER

  • Juho Vainio Foundation

    collaborator OTHER

  • Ministry of Education and Culture, Finland

    collaborator OTHER

  • University of Turku

    lead OTHER

Principal Investigators

  • Sari Stenholm, Prof · University of Turku

  • Tuija Leskinen, Dr · University of Turku

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-06
Primary Completion
2020-03-01
Completion
2020-03-01

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03320746 on ClinicalTrials.gov